The day's most important news and information. A Fourth Estate® Service

Monday, June 21, 2021
Pfizer CEO Albert Bourla filed to sell $5.6 million of his company’s stocks the day it announced positive data about the COVID-19 vaccine it is currently developing. The transaction was part of a regularly scheduled plan set up by Bourla to sell some of his Pfizer shares.

This article is archived.

Subscribe or log in to the Daily Newsbrief and gain access.


Premium Access

Unlimited access is just $1 /week
You can cancel anytime.
  • Unlimited articles with no ads
  • Access with any of your devices
  • Access to archived articles
  • The Daily News Brief newsletter
  • Special offers
  • Early access to new features


Not ready for a subscription? Simply sign up here
(no credit card required) to get 5 free articles each month.